GFAP and glioblastoma: In another study, utilising sensitive immunocytochemical detection, with glial fibrillary acidic protein (GFAP) as a marker for CTCs in peripheral blood cytospin preparations, putative CTC cells were detected in 29 out 141 GBM patients (73).